461 related articles for article (PubMed ID: 26408257)
21. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
[TBL] [Abstract][Full Text] [Related]
22. Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry.
Schultz KA; Harris A; Messinger Y; Sencer S; Baldinger S; Dehner LP; Hill DA
Fam Cancer; 2016 Jan; 15(1):105-10. PubMed ID: 26289771
[TBL] [Abstract][Full Text] [Related]
23.
Ricarte-Filho JC; Casado-Medrano V; Reichenberger E; Spangler Z; Scheerer M; Isaza A; Baran J; Patel T; MacFarland SP; Brodeur GM; Stewart DR; Baloch Z; Bauer AJ; Wasserman JD; Franco AT
Front Endocrinol (Lausanne); 2023; 14():1083382. PubMed ID: 36896180
[TBL] [Abstract][Full Text] [Related]
24. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
[TBL] [Abstract][Full Text] [Related]
25. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
[TBL] [Abstract][Full Text] [Related]
26. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
Kim MS; Lee SH; Yoo NJ; Lee SH
Histopathology; 2013 Sep; 63(3):436-8. PubMed ID: 23763383
[No Abstract] [Full Text] [Related]
27. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.
Vedanayagam J; Chatila WK; Aksoy BA; Majumdar S; Skanderup AJ; Demir E; Schultz N; Sander C; Lai EC
Nat Commun; 2019 Aug; 10(1):3682. PubMed ID: 31417090
[TBL] [Abstract][Full Text] [Related]
29. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
[TBL] [Abstract][Full Text] [Related]
30. DICER1 mutations in a patient with an ovarian Sertoli-Leydig tumor, well-differentiated fetal adenocarcinoma of the lung, and familial multinodular goiter.
Wu Y; Chen D; Li Y; Bian L; Ma T; Xie M
Eur J Med Genet; 2014; 57(11-12):621-5. PubMed ID: 25451712
[TBL] [Abstract][Full Text] [Related]
31. DICER1 hotspot mutations in non-epithelial gonadal tumours.
Witkowski L; Mattina J; Schönberger S; Murray MJ; Choong CS; Huntsman DG; Reis-Filho JS; McCluggage WG; Nicholson JC; Coleman N; Calaminus G; Schneider DT; Arseneau J; Stewart CJ; Foulkes WD
Br J Cancer; 2013 Nov; 109(10):2744-50. PubMed ID: 24136150
[TBL] [Abstract][Full Text] [Related]
32. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract][Full Text] [Related]
33. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
Zhang X; Shen D; Wang Y
Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
[TBL] [Abstract][Full Text] [Related]
34. Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms.
McCluggage WG; Chong AL; de Kock L; Foulkes WD
Histopathology; 2020 Aug; 77(2):223-230. PubMed ID: 32333409
[TBL] [Abstract][Full Text] [Related]
35. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
36. Ovarian Sertoli-Leydig Cell Tumor with Elevated Inhibin B as a Cause of Secondary Amenorrhea in an Adolescent with Germ Line DICER1 Mutation.
Luke AM; Moroney JW; Snitchler A; Whiteway SL
J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):598-600. PubMed ID: 28502826
[TBL] [Abstract][Full Text] [Related]
37. Bilateral Ovarian Sertoli-Leydig Cell Tumors Harboring
Hughes CE; Liang J; Paulson V; Wang H
Fetal Pediatr Pathol; 2023 Jun; 42(3):472-478. PubMed ID: 36121434
[No Abstract] [Full Text] [Related]
38. Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis.
Apellaniz-Ruiz M; Sabbaghian N; Chong AL; de Kock L; Cetinkaya S; Bayramoğlu E; Dinjens WNM; McCluggage WG; Wagner A; Yilmaz AA; Foulkes WD
Fam Cancer; 2023 Oct; 22(4):487-493. PubMed ID: 37248399
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of multiple DICER1 mutations in an adolescent.
Wu MK; de Kock L; Conwell LS; Stewart CJ; King BR; Choong CS; Hussain K; Sabbaghian N; MacRae IJ; Fabian MR; Foulkes WD
Endocr Relat Cancer; 2016 Feb; 23(2):L1-5. PubMed ID: 26545620
[No Abstract] [Full Text] [Related]
40. Moderately differentiated Sertoli-Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome.
Khan S; Hodgson A
Int J Gynecol Cancer; 2023 Dec; 33(12):1981-1982. PubMed ID: 37543372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]